Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | G6PD | P11413 | 1/20 | 0.60 |
| ▸ | IDE | P14735 | 1/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.41 |
| ▸ | PHLPP2 | Q6ZVD8 | 1/20 | 0.41 |
| ▸ | CA12 | O43570 | 4/20 | 0.41 |
| ▸ | CA1 | P00915 | 4/20 | 0.41 |
| ▸ | CA2 | P00918 | 4/20 | 0.41 |
| ▸ | CA4 | P22748 | 4/20 | 0.41 |
| ▸ | CA6 | P23280 | 4/20 | 0.41 |
| ▸ | CA5A | P35218 | 4/20 | 0.41 |
| ▸ | CA7 | P43166 | 4/20 | 0.41 |
| ▸ | CA9 | Q16790 | 4/20 | 0.41 |
| ▸ | CA14 | Q9ULX7 | 4/20 | 0.41 |
| ▸ | CA5B | Q9Y2D0 | 4/20 | 0.41 |
| ▸ | PKM | P14618 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5353740 | 0.88 | G6PD (0.56) | G6PDIDESMN1; SMN2L3MBTL1CA12 | |
| SCHEMBL9815491 | 0.86 | G6PD (0.46) | G6PDIDESMN1; SMN2L3MBTL1PHLPP2 | |
| SCHEMBL343565 | 0.86 | G6PD (0.55) | G6PDIDESMN1; SMN2ENPP2PHLPP2 | |
| SCHEMBL9815495 | 0.84 | ALDH1A1 (0.52) | G6PDIDESMN1; SMN2L3MBTL1PHLPP2 | |
| SCHEMBL898422 | 0.82 | G6PD (0.64) | G6PDIDESMN1; SMN2ENPP2CA12 | |
| SCHEMBL6932811 | 0.81 | G6PD (0.58) | G6PDIDEENPP2PHLPP2CA12 | |
| SCHEMBL9175606 | 0.80 | L3MBTL1 (0.61) | G6PDIDEL3MBTL1CA12CA1 | |
| SCHEMBL11685666 | 0.80 | ALDH1A1 (0.51) | G6PDIDESMN1; SMN2CA12CA1 | |
| SCHEMBL30908409 | 0.78 | CYP3A4 (0.50) | G6PDIDESMN1; SMN2L3MBTL1CA12 | |
| SCHEMBL20150187 | 0.78 | CYP3A4 (0.50) | G6PDIDESMN1; SMN2L3MBTL1CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025215201-A1 | PANNEXIN-1 INHIBITORS AND USES THEREOF | PANNTHERAPI (FR) | 2025-10-16 | — | — | WO | disclosed |
| US-9493480-B2 | Monomeric trioxane amide sulfur compounds | THE JOHNS HOPKINS UNIVERSITY (US) | 2016-11-15 | — | — | US | disclosed |
| US-20150183798-A1 | MONOMERIC TRIOXANE AMIDE SULFUR COMPOUNDS | THE JOHNS HOPKINS UNIVERSITY (US) | 2015-07-02 | — | — | US | disclosed |
| EP-1325920-B1 | N-SUBSTITUTED BENZOTHIOPHENESULFONAMIDE DERIVATIVES | TOA EIYO LTD (JP) | 2010-08-25 | — | — | EP | disclosed |
| US-7700655-B2 | Antiallergic agents | INSTITUTE OF MEDICINAL MOLECULAR DESIGN, INC. (JP) | 2010-04-20 | — | — | US | disclosed |
| US-7399781-B2 | N-substituted benzothiophenesulfonamide derivatives | TOA EIYO LTD. (JP) | 2008-07-15 | — | — | US | disclosed |
| US-20080090779-A1 | ANTIALLERGIC AGENTS | INSTITUTE OF MEDICINAL MOLECULAR DESIGN, INC. (JP) | 2008-04-17 | — | — | US | disclosed |
| US-20070185059-A1 | Antiallergic agents | INSTITUTE OF MEDICINAL MOLECULAR DESIGN, INC. (JP) | 2007-08-09 | — | — | US | disclosed |
| US-20070185110-A1 | Antiallergic agents | INSTITUTE OF MEDICINAL MOLECULAR DESIGN, INC. (JP) | 2007-08-09 | — | — | US | disclosed |
| US-7071220-B2 | N-substituted benzothiophenesulfonamide derivatives | TOA EIYO LTD. (JP) | 2006-07-04 | — | — | US | disclosed |
| US-4358526-A | MAGENTA AZO DYES; COLORFASTNESS | FUJI PHOTO FILM CO., LTD. (JP) | 1982-11-09 | — | — | US | disclosed |
| EP-0036081-A1 | Azo dyestuffs as well as their preparation and their use in dyeing synthetic fibres | BAYER AG (DE) | 1981-09-23 | — | — | EP | disclosed |
| US-4217271-A | Basic azo dyestuffs containing a n-picolinium alkylene amino phenyl group | IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) | 1980-08-12 | — | — | US | disclosed |
| US-4189428-A | DYEABILITY, COLORFASTNESS, RESISTANCE TO SUBLIMATION, IMPROVED BRIGHTNESS | EASTMAN KODAK COMPANY (US) | 1980-02-19 | — | — | US | disclosed |
| US-4153413-A | DYEING POLYESTER OR CELLULOSE TRIACETATE WITH A DISPERSE AZO DYESTUFF, HEAT TREATMENT, PADDING, PRINTING | IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) | 1979-05-08 | — | — | US | disclosed |
| US-4140683-A | DISPERSE DYES FOR POLYESTERS | EASTMAN KODAK COMPANY (US) | 1979-02-20 | — | — | US | disclosed |
| US-4134723-A | DYEING AROMATIC POLYESTER/POLYAMIDE OR AROMATIC POLYESTER/CELLULOSE BLENDS WITH DISPERSE MONOAZO DYE, ALKALINE BATH | IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) | 1979-01-16 | — | — | US | disclosed |
| US-4060544-A | COUPLERS | GAF CORPORATION (US) | 1977-11-29 | — | — | US | disclosed |
| US-4049643-A | DYES FOR POLYESTERS | EASTMAN KODAK COMPANY (US) | 1977-09-20 | — | — | US | disclosed |
| US-4039524-A | Keto-amido containing phenylazo benzothiazole dyestuffs | GAF CORPORATION (US) | 1977-08-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080090779-A1 | ANTIALLERGIC AGENTS | NAT1, EPX, HRH2 | G6PD 2078/4885IDE 3235/4885SMN1; SMN2 4693/4885 |
| US-20070185110-A1 | Antiallergic agents | NAT1, EPX, AHR | G6PD 2016/4885IDE 3099/4885SMN1; SMN2 4695/4885 |
| US-20150183798-A1 | MONOMERIC TRIOXANE AMIDE SULFUR COMPOUNDS | AS3MT, SQOR, TST | G6PD 51/4885IDE 4725/4885SMN1; SMN2 1555/4885 |
| US-20070185059-A1 | Antiallergic agents | NAT1, EPX, AHR | G6PD 2048/4885IDE 3201/4885SMN1; SMN2 4709/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.